Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-012217
Filing Date
2012-08-02
Accepted
2012-08-02 07:26:09
Documents
1
Period of Report
2012-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5138
  Complete submission text file 0001179110-12-012217.txt   6512
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O METABOLIX 21 ERIE STREET CAMBRIDGE MA 02139
Business Address
Sinskey Anthony J (Reporting) CIK: 0001368753 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35409 | Film No.: 121001714